**公司业绩与市场表现**巨子生物(02367。HK)在2024年表现出色,实现营收55.4亿元人民币,同比增长57.2%,归母净利润达21.5亿元人民币,同比增长42.1%。经调整利润为21.5亿元人民币,同比增长46.5%,符合市场预期。公司股价在过去一年中上涨了46.25%,显示出强劲的市场认可度。此外,公司拟派发每股0.6021元人民币的股息及特别股息0.5921元人民币,以当前股价计算,...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.